ArticleHuman vaccines & immunotherapeutics2026
Anlotinib plus envafolimab as neoadjuvant therapy in a patient with chemotherapy-refractory advanced endometrial cancer: A case report.
Jinpeng Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.